Cooper Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.68M Buy
5,776
+502
+10% +$592K 0.53% 39
2026
Q2
$6.33M Buy
5,274
+564
+12% +$576K 0.52% 39
2026
Q1
$4.33M Buy
4,710
+208
+5% +$211K 0.44% 42
2025
Q4
$4.84M Sell
4,502
-286
-6% -$273K 0.51% 34
2025
Q3
$3.65M Buy
4,788
+229
+5% +$170K 0.4% 42
2025
Q2
$3.55M Buy
4,559
+1,583
+53% +$1.23M 0.42% 43
2025
Q1
$2.46M Buy
2,976
+321
+12% +$267K 0.32% 61
2024
Q4
$2.05M Buy
2,655
+695
+35% +$575K 0.25% 72
2024
Q3
$1.74M Buy
1,960
+333
+20% +$299K 0.23% 78
2024
Q2
$1.47M Buy
1,627
+106
+7% +$84.8K 0.22% 86
2024
Q1
$1.18M Buy
1,521
+211
+16% +$150K 0.19% 100
2023
Q4
$764K Buy
1,310
+4
+0.3% +$2.34K 0.14% 139
2023
Q3
$702K Buy
1,306
+142
+12% +$73.2K 0.17% 137
2023
Q2
$546K Buy
1,164
+184
+19% +$77.2K 0.14% 176
2023
Q1
$337K Buy
980
+301
+44% +$102K 0.09% 221
2022
Q4
$248K Sell
679
-93
-12% -$33K 0.08% 249
2022
Q3
$250K Buy
772
+46
+6% +$14.6K 0.09% 209
2022
Q2
$235K Buy
+726
New +$218K 0.09% 215

Other funds holding LLY

Cooper Financial Group's LLY Position: Q3 2026 in Review

Cooper Financial Group increased its Eli Lilly (LLY) stake by 9.5% in Q3 2026, buying an estimated $592K and bringing the position to 5,776 shares worth $6.68M. The position accounts for 0.53% of the portfolio, ranked #39.

Cooper Financial Group first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. 4,622 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cooper Financial Group held 5,776 shares of Eli Lilly worth $6.68M as of Q3 2026.
  • Cooper Financial Group bought 502 Eli Lilly shares in Q3 2026, an estimated $592K.
  • Eli Lilly made up 0.53% of Cooper Financial Group's portfolio in Q3 2026, its #39 holding.
  • Cooper Financial Group first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
  • 4,622 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cooper Financial Group's 13F filing for Q3 2026, filed 7 Oct 2026.